newsfilter
← Latest News
PR Newswire·

Canntab Engages Hamish Sutherland as Strategic Advisor

TORONTO, April 13, 2022 /PRNewswire/ - Canntab Therapeutics Limited (CSE:PILL) (OTCQB:CTABF) (FRA: TBF1) (the "Company" or "Canntab") a leading innovator in cannabinoid and terpene blends in hard pill form for therapeutic applications, is pleased to anno